Pharsight

Drugs that contain Ritlecitinib Tosylate

1. Litfulo patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US9617258 PFIZER Pyrrolo[2,3-d]pyrimidinyl, pyrrolo[2,3-b]pyrazinyl and pyrrolo[2,3-d]pyridinyl acrylamides
Dec, 2034

(11 years from now)

Drug Exclusivity Drug Exclusivity Expiration
New Chemical Entity Exclusivity (NCE) Jun 23, 2028

NCE-1 date: 2027-06-24

Market Authorisation Date: 23 June, 2023

Treatment: NA

Dosage: CAPSULE;ORAL

More Information on Dosage

LITFULO family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic